Compare Cronos Group Inc (CRON) vs Spotify Technology (SPOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Spotify Technology — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Spotify Technology trades at $530 (market cap $108.22B). The key difference: Spotify Technology is far larger — about 91.7× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Spotify Technology nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Spotify Technology for 111 Days on average.
| CRON | SPOT | |
|---|---|---|
Market Cap | $1.18B | $108.22B |
Volume | 968,037 | 1,655,796 |
Sector | Health | Media |
52-Week High | $3.55 | $692.04 |
52-Week Low | $2.30 | $412.75 |
Typical Hold Time | 22 Days | 111 Days |
Enterprise Value | $387.62M | $98.23B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
Spotify (SPOT) trades at $512.92, up 5.08% with strong bullish momentum. The stock shows robust fundamentals with revenue growth from $17.19B in 2025 to projected $18.1B in 2026, while net income margin expanded to 18.43%. Technical indicators signal bullish sentiment with price above key support at $497. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results pending.
Outlook remains positive with analyst consensus target of $608.18 representing 18.6% upside. Key opportunities include gross margin expansion and new monetization tools, while risks involve competitive pressures and market volatility. Wall Street maintains strong buy sentiment with 62% of analysts recommending purchase.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
